( NASDAQ-NMS:TELK )

News from telik, inc A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 28, 2014, 09:30 ET Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers

Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company that merged with MabVax Therapeutics, Inc. on July 8, 2014, announced...


Aug 25, 2014, 09:30 ET Telik Receives $1.5 Million National Cancer Institute Contract to Develop Novel Antibody-based PET Imaging Agent for Pancreatic Cancer

Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company that merged with MabVax Therapeutics, Inc. on July 8, 2014, announced...


Aug 11, 2014, 09:00 ET Telik Announces New Board of Director Members to Oversee Reinvigorated Cancer Therapy Pipeline Resulting from the Recent Merger with MabVax Therapeutics, Inc.

 Telik, Inc. (OTCQB: TELK), a clinical stage oncology drug development company, which recently merged with MabVax Therapeutics, Inc. on July 8,...


Aug 04, 2014, 09:00 ET Telik Announces Plans for Special Meeting of Stockholders and Transition to MabVax Therapeutics Holdings, Inc.

 As previously announced, MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, and Telik, Inc. (OTCQB: TELK), aclinical...


Jul 09, 2014, 09:30 ET MabVax Therapeutics And Telik Announce Closing of Merger

MabVax Therapeutics, Inc., a privately held cancer immunotherapy company, and Telik, Inc. (Nasdaq: TELK), a publicly-traded clinical stage oncology...


May 15, 2014, 16:05 ET Telik Announces First Quarter 2014 Financial Results

Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2014.  The net loss for the quarter ended...


May 12, 2014, 16:30 ET Telik and MabVax Therapeutics Announce Definitive Merger Agreement

 Telik, Inc. (Nasdaq: TELK), a clinical stage oncology drug development company, and MabVax Therapeutics, Inc., a privately held cancer...


Mar 10, 2014, 16:15 ET Telik Announces Fourth Quarter And 2013 Year End Financial Results

 Telik, Inc. (Nasdaq: TELK) reported a net loss of $0.8 million, or $0.17 per share, for the three months ended December 31, 2013, compared...


Nov 12, 2013, 16:20 ET Telik Announces Third Quarter 2013 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported a net loss of $1.1 million, or $0.25 per share, for the third quarter ended September 30, 2013,...


Aug 09, 2013, 16:15 ET Telik Announces Second Quarter 2013 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported a net loss of $1.4 million, or $0.30 per share, for the second quarter ended June 30, 2013, compared...


May 10, 2013, 16:30 ET Telik Announces First Quarter 2013 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2013.  The net loss for the quarter...


Mar 15, 2013, 16:30 ET Telik Announces Fourth Quarter And 2012 Year End Financial Results And 2013 Financial Guidance

 Telik, Inc. (Nasdaq: TELK) reported a net loss of $1.8 million, or $0.66 per share, for the three months ended December 31, 2012, compared...


Jan 22, 2013, 17:30 ET Telik Announces Preliminary Agreement On Design Of Phase 3 Registration Trial Of Telintra® In Low To Intermediate-1 Risk Myelodysplastic Syndrome

 Telik, Inc. (Nasdaq: TELK) announced the completion of an End of Phase 2 meeting with the US Food and Drug Administration (FDA). ...


Jan 11, 2013, 19:23 ET Telik Announces Orphan Designation Of Telintra® For Treatment Of Myelodysplastic Syndrome

 Telik, Inc. (Nasdaq: TELK) was notified today that its product candidate, ezatiostat HCL (Telintra), has been granted orphan drug designation...


Dec 12, 2012, 16:20 ET Telik Announces Telintra® Clinical Publication at the 54th Annual Meeting of the American Society of Hematology

Telik, Inc. (Nasdaq: TELK) announced today the publication of a clinical trial abstract in the proceedings of the 54th Annual Meeting of the...


Nov 09, 2012, 16:15 ET Telik Announces Third Quarter 2012 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported a net loss of $1.9 million, or $0.78 per share, for the third quarter ended September 30, 2012,...


Aug 10, 2012, 16:05 ET Telik Announces Second Quarter 2012 Financial Results

Telik, Inc. (Nasdaq: TELK) today reported a net loss of $2.1 million, or $1.11 per share, for the second quarter ended June 30, 2012, compared with...


May 09, 2012, 16:15 ET Telik Announces First Quarter 2012 Financial Results

 Telik, Inc. (Nasdaq: TELK) today reported financial results for the first quarter ended March 31, 2012.  The net loss for the quarter...


Apr 17, 2012, 16:59 ET Telik Regains Compliance With Minimum Bid Price Requirement

 Telik, Inc. (Nasdaq: TELK) today announced that it has received from The Nasdaq Stock Market notification that Telik has regained compliance...


Mar 30, 2012, 13:00 ET Telik Announces Reverse Split of Common Stock

 Telik, Inc. (NASDAQ: TELK) today announced a 1-for-30 reverse split of its common stock.  Telik's common stock will begin trading on a...


Feb 23, 2012, 16:05 ET Telik Announces Fourth Quarter and 2011 Year End Financial Results and 2012 Financial Guidance

Telik, Inc. (Nasdaq: TELK) reported a net loss of $2.5 million, or $0.05 per share, for the three months ended December 31, 2011, compared with a...


Feb 21, 2012, 09:05 ET Telik Announces Expansion of Phase 2 Trial of Telcyta in Hematologic Malignancies

Telik, Inc. (Nasdaq: TELK) today announced that the Phase 2 investigator-led Telcyta trial in hematologic malignancies has been expanded to an...


Feb 08, 2012, 09:05 ET Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference

Telik, Inc. (Nasdaq: TELK) today announced that CEO Michael M. Wick, M.D., Ph.D. will provide a corporate overview at the 14th Annual BIO CEO...


Jan 04, 2012, 09:00 ET Telik Announces Presentation and Webcast at 5th Annual OneMedForum Conference

 Telik, Inc. (Nasdaq: TELK) today announced that CEO Michael M. Wick, M.D., Ph.D. will provide a corporate update at the 5th Annual...